Evidence map›Paper›PMID 33908276›Full record

ArticleJournal of managed care & specialty pharmacy2021

A decade of increases in Medicare Part B pharmaceutical spending: what are the drivers?

Alvaro San-Juan-Rodriguez, Walid F Gellad, William H Shrank, Chester B Good, Inmaculada Hernandez

Abstract read
In one paragraph

Article in Journal of managed care & specialty pharmacy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Incorporating Added Therapeutic Benefit and Domestic Reference Pricing Into Medicare Payment for Expensive Part B Drugs.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2023
    Article
  3. Article
  4. Reforming Drug Price Regulation: Using Tools That Work.Inquiry : a journal of medical care organization, provision and financing
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alvaro San-Juan-RodriguezDepartment of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA.
Walid F GelladDivision of General Internal Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA.
William H ShrankHumana, Louisville, KY.
Chester B GoodInsurance Services Division, UPMC Health Plan, Pittsburgh, PA.
Inmaculada HernandezDepartment of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA.

Funding

Patient and System-Level Determinants of Oral Anticoagulation Use in Atrial FibrillationK01HL142847 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HERNANDEZ, INMACULADA · 2018 to 2022
$798k
NHLBI NIH HHS K01 HL142847
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug CostsDrug UtilizationHealth ExpendituresHumansInsurance Claim ReviewMedicare Part BRetrospective StudiesUnited States

Identifiers

PMID33908276
PMCPMC8906185

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.